{"id":6477,"date":"2018-04-20T18:30:11","date_gmt":"2018-04-20T22:30:11","guid":{"rendered":"http:\/\/lifeinsurance-orleans.ca\/Life-Insurance-Blog\/?guid=894024844686b1bf7753d989893cb3cb"},"modified":"2018-04-20T18:30:11","modified_gmt":"2018-04-20T22:30:11","slug":"zenabis-receives-cannabis-plant-sales-license","status":"publish","type":"post","link":"https:\/\/blog.lifeinsurance-orleans.ca\/index.php\/2018\/04\/20\/zenabis-receives-cannabis-plant-sales-license\/","title":{"rendered":"Zenabis Receives Cannabis Plant Sales License"},"content":{"rendered":"<p>Zenabis Ltd. (\u201cZenabis\u201d or \u201cthe Company\u201d), a licensed producer, is pleased to announce that Health Canada has issued an amendment to its Producer\u2019s License. Zenabis is now eligible to sell clones to other licensed producers under current Access to Cannabis for Medical Purposes Regulations (ACMPR). The amended license also opens the door for the Company to meet national demand for high-quality cannabis.<\/p>\n<p>The amended sales license was issued for Zenabis\u2019 380,000 square foot facility in Atholville, New Brunswick, and is effective from April 13, 2018 through January 19, 2021. Zenabis received its cultivation license for Atholville in August 2017, and has since been growing top of the line, high-yielding, pharmaceutical-grade cannabis plants and preparing for its release of top quality cannabis strains.<\/p>\n<p>\u201cObtaining our license to sell cannabis plants is a significant milestone for Zenabis and an incredible opportunity for innovation,\u201d stated Kevin Coft, CEO of Zenabis, \u201cWe take pride in the quality and craftsmanship of our cannabis plants and with this amended license can now support the Canadian cannabis community.\u201d<\/p>\n<p>This amended license brings the Company one step closer to increasing its global presence as the prominent industry leader in cannabis innovation, production, and distribution of high-demand cannabis strains.<\/p>\n<p>For a list of available strains, or to place an order, please contact Zenabis at by phone at 1-855-936-2247 or by email at <a href=\"mailto:info@zenabis.com\" rel=\"nofollow\">info@zenabis.com<\/a><\/p>\n<p><b>ABOUT ZENABIS LTD.<\/b><\/p>\n<p>Zenabis is a privately-held, cannabis company with one of the largest, federally licensed indoor medical cultivation footprints in Canada. Zenabis currently operates two licensed production facilities with more than 400,000 square feet of fully certified growing space in British Columbia and New Brunswick. Our strategic location on Canada\u2019s coasts enables us to leverage our global partnerships and provides us with direct access to international markets. The company is currently working towards globally recognized GMP certifications.<\/p>\n<p>Zenabis has one of the most experienced management teams in the industry, with an extensive background in commercialized cultivation, retail, and pharmaceutical sales. Our growing team has more than two decades of experience in organic cultivation and distribution of herbs and nutraceutical products throughout the Americas, North Africa, and the Middle East. Our sales team has more than two decades in product development, commercialization, and retail and pharmaceutical sales including international distribution.<\/p>\n<p><b>If you would like more information, please contact Kevin Coft at <\/b><a href=\"mailto:media@zenabis.com\" rel=\"nofollow\"><b>media@zenabis.com<\/b><\/a><b>.<\/b><\/p>\n<p>&lt;<\/p>\n<p>p class=&#8221;bwalignc&#8221;><br \/>\n<img decoding=\"async\" alt=\"\" src=\"http:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20180420005842r1&amp;sid=cnpm1&amp;distro=nx&amp;lang=en\" \/><span class=\"bwct31415\" \/><\/p>\n<p><b>Contacts<\/b><\/p>\n<p>Zenabis Ltd.<br \/>Kevin Coft<br \/><a href=\"mailto:media@zenabis.com\">media@zenabis.com<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Zenabis Ltd. (&ldquo;Zenabis&rdquo; or &ldquo;the Company&rdquo;), a licensed producer, is pleased to announce that Health Canada has issued an amendment to its Producer&rsquo;s License. Zenabis is now eligible to sell clones to other licensed producers under current Access to Cannabis for Medical Purposes Regulations (ACMPR). The amended license also opens the door for the Company [&hellip;]<\/p>\n","protected":false},"author":578,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[],"tags":[],"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/blog.lifeinsurance-orleans.ca\/index.php\/wp-json\/wp\/v2\/posts\/6477"}],"collection":[{"href":"https:\/\/blog.lifeinsurance-orleans.ca\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blog.lifeinsurance-orleans.ca\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blog.lifeinsurance-orleans.ca\/index.php\/wp-json\/wp\/v2\/users\/578"}],"replies":[{"embeddable":true,"href":"https:\/\/blog.lifeinsurance-orleans.ca\/index.php\/wp-json\/wp\/v2\/comments?post=6477"}],"version-history":[{"count":1,"href":"https:\/\/blog.lifeinsurance-orleans.ca\/index.php\/wp-json\/wp\/v2\/posts\/6477\/revisions"}],"predecessor-version":[{"id":6480,"href":"https:\/\/blog.lifeinsurance-orleans.ca\/index.php\/wp-json\/wp\/v2\/posts\/6477\/revisions\/6480"}],"wp:attachment":[{"href":"https:\/\/blog.lifeinsurance-orleans.ca\/index.php\/wp-json\/wp\/v2\/media?parent=6477"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blog.lifeinsurance-orleans.ca\/index.php\/wp-json\/wp\/v2\/categories?post=6477"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blog.lifeinsurance-orleans.ca\/index.php\/wp-json\/wp\/v2\/tags?post=6477"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}